Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
319,29 USD | +0,75 % | +1,04 % | +10,86 % |
01/11 | AMGEN INC. : UBS neutre sur le dossier | ZM |
31/10 | AMGEN INC. : Goldman Sachs optimiste sur le dossier | ZM |
Groupe Amgen Inc. : Graphique Relationnel
Sociétés privées appartenant au même groupe que AMGEN INC.
Société | Dirigeant |
---|---|
Amgen NV
Amgen NV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen NV is a pharmaceutical company based in Diegem, Belgium. The Belgian company is focused on developing innovative therapies to address serious illnesses and improve the lives of patients. Amgen is committed to advancing scientific research and delivering high-quality medicines to patients worldwide. The CEO of the company is Gabor Sztaniszlav. | Gabor Sztaniszlav |
Amgen Global Finance BV | - |
Zonebourse is also available in this country: United States.
Switch edition